Skip to main content

Closed

BIO: Bio-Rad Laboratories, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth-3.9% / yr

Operating margin9.2%

ROIC2.0%

Financially safe

Strong

Debt / equity0.20×

Interest coverage4.9×

Current ratio3.21×

Valuation

Unrated

P/E ratio53.5×

Bio-Rad Laboratories, Inc.

BIONew York Stock Exchange·USD·Closed

Bio-Rad Laboratories, Inc.

BIONew York Stock Exchange·USD·Closed

$325.48

−0.38%

$325.48

−$1.24 (0.38%)

52W Range

83thpctl

Volume

0.37×avg

Mkt Cap

8.80BUSD

P/E

53.5TTM

Div Yield

–ann

52W Range

83thpctl

Volume

0.37×avg

Market Cap

8.80BUSD

P/E Ratio

53.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings